Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., University of London (UK) 1996
• 

  Duke Appointment History

  • Medical Instructor in the Department of Medicine, Medicine, Cardiology, Medicine 2013 - 2017
• Research
• 

  Selected Grants

  • Sfrp2 induces in situ c-Kit cell differentiation into cardiomyocytes via Wnt11-Fzd5 mediated b-catenin inhibition awarded by National Institutes of Health 2018 - 2022
  • Novel strategy for Enhancing miRNA as a Therapeutic for Cardiac Regeneration awarded by National Institutes of Health 2016 - 2020
  • Integrated Cellular and Tissue Engineering for Ischemic Heart Disease awarded by University of Alabama at Birmingham 2016 - 2018
  • Sfrp2 and Cardiac Progenitor Cells in Regenerative Response to Ischemic Injury awarded by National Institutes of Health 2005 - 2016
  • Gene Therapy for Long-Term Myocardial Protection awarded by National Institutes of Health 2003 - 2014
  • Genetically Altered Mesenchymal Stem Cell; Paracrine Effect on Neovascularization awarded by National Institutes of Health 2003 - 2014
• Publications & Artistic Works
• 

  Selected Publications

  • Journal Articles

    • Bareja, A, Patel, S, Hodgkinson, CP, Payne, A, and Dzau, VJ. "Understanding the mechanism of bias signaling of the insulin-like growth factor 1 receptor: Effects of LL37 and HASF." Cellular signalling 46 (February 27, 2018): 113-119.  Full Text
    • Dal-Pra, S, Hodgkinson, CP, Mirotsou, M, Kirste, I, and Dzau, VJ. "Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo." Circulation research 120, no. 9 (April 2017): 1403-1413.  Full Text
    • Bareja, A, Hodgkinson, CP, Payne, AJ, Pratt, RE, and Dzau, VJ. "HASF (C3orf58) is a novel ligand of the insulin-like growth factor 1 receptor." Biochemical Journal 474, no. 5 (February 2017): 771-780.  Full Text
    • Li, Y, Dal-Pra, S, Mirotsou, M, Jayawardena, TM, Hodgkinson, CP, Bursac, N, and Dzau, VJ. "Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs." Scientific reports 6 (December 12, 2016): 38815-.  Full Text
    • Wang, X, Hodgkinson, CP, Lu, K, Payne, AJ, Pratt, RE, and Dzau, VJ. "Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog." Scientific reports 6 (March 15, 2016): 23017-.  Full Text
    • Hodgkinson, CP, Bareja, A, Gomez, JA, and Dzau, VJ. "Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology." Circulation research 118, no. 1 (January 2016): 95-107. (Review)  Full Text
    • Hodgkinson, CP, Kang, MH, Dal-Pra, S, Mirotsou, M, and Dzau, VJ. "MicroRNAs and Cardiac Regeneration." Circulation research 116, no. 10 (May 2015): 1700-1711. (Review)  Full Text
    • Hodgkinson, CP, and Dzau, VJ. "Conserved microRNA program as key to mammalian cardiac regeneration: insights from zebrafish." Circulation research 116, no. 7 (March 2015): 1109-1111.  Full Text
    • Jayawardena, TM, Finch, EA, Zhang, L, Zhang, H, Hodgkinson, CP, Pratt, RE, Rosenberg, PB, Mirotsou, M, and Dzau, VJ. "MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function." Circulation research 116, no. 3 (January 2015): 418-424.  Full Text
    • Hodgkinson, CP, Gomez, JA, Payne, AJ, Zhang, L, Wang, X, Dal-Pra, S, Pratt, RE, and Dzau, VJ. "Abi3bp regulates cardiac progenitor cell proliferation and differentiation." Circulation research 115, no. 12 (December 2014): 1007-1016.  Full Text
    • Jayawardena, TM, Finch, EA, Zhang, L, Zhang, H, Hodgkinson, CP, Pratt, RE, Rosenberg, PB, Mirotsou, M, and Dzau, VJ. "MicroRNA induced cardiac reprogramming in vivo evidence for mature cardiac myocytes and improved cardiac function." Circulation Research 116, no. 3 (October 28, 2014): 418-424.  Full Text
    • Hodgkinson, CP, Gomez, JA, Payne, AJ, Zhang, L, Wang, X, Dal-Pra, S, Pratt, RE, and Dzau, VJ. "Abi3bp regulates cardiac progenitor cell proliferation and differentiation." Circulation Research 115, no. 12 (January 1, 2014): 1007-1016.
    • Huang, J, Guo, J, Beigi, F, Hodgkinson, CP, Facundo, HT, Zhang, Z, Espinoza-Derout, J, Zhou, X, Pratt, RE, Mirotsou, M, and Dzau, VJ. "HASF is a stem cell paracrine factor that activates PKC epsilon mediated cytoprotection." J Mol Cell Cardiol 66 (January 2014): 157-164.  Full Text  Link to Item
    • Hodgkinson, CP, Naidoo, V, Patti, KG, Gomez, JA, Schmeckpeper, J, Zhang, Z, Davis, B, Pratt, RE, Mirotsou, M, and Dzau, VJ. "Abi3bp is a multifunctional autocrine/paracrine factor that regulates mesenchymal stem cell biology." Stem Cells 31, no. 8 (August 2013): 1669-1682.  Full Text  Link to Item
    • Lin, Y-T, Verma, A, and P. Hodgkinson, C. "Toll-Like Receptors and Human Disease: Lessons from Single Nucleotide Polymorphisms." Current Genomics 13, no. 8 (October 1, 2012): 633-645.  Full Text
    • Hodgkinson, CP, and Ye, S. "Toll-like receptors, their ligands, and atherosclerosis." TheScientificWorldJournal 11 (February 14, 2011): 437-453. (Review)  Full Text
    • Hodgkinson, CP, Gomez, JA, Mirotsou, M, and Dzau, VJ. "Genetic engineering of mesenchymal stem cells and its application in human disease therapy." Hum Gene Ther 21, no. 11 (November 2010): 1513-1526. (Review)  Full Text  Link to Item
    • Laxton, RC, Hu, Y, Duchene, J, Zhang, F, Zhang, Z, Leung, K-Y, Xiao, Q, Scotland, RS, Hodgkinson, CP, Smith, K, Willeit, J, López-Otín, C, Simpson, IA, Kiechl, S, Ahluwalia, A, Xu, Q, and Ye, S. "A role of matrix metalloproteinase-8 in atherosclerosis." Circulation research 105, no. 9 (October 2009): 921-929.  Full Text
    • Hodgkinson, CP, Laxton, RC, Patel, K, and Ye, S. "Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis." Arteriosclerosis, thrombosis, and vascular biology 28, no. 12 (December 2008): 2275-2281.  Full Text
    • Hodgkinson, CP, and Ye, S. "Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression." Pharmacogenetics and genomics 18, no. 9 (September 2008): 803-813.  Full Text
    • Hodgkinson, CP, Patel, K, and Ye, S. "Functional Toll-like receptor 4 mutations modulate the response to fibrinogen." Thrombosis and haemostasis 100, no. 2 (August 2008): 301-307.
    • Smithers, NP, Hodgkinson, CP, Cuttle, M, and Sale, GJ. "Insulin-triggered repositioning of munc18c on syntaxin-4 in GLUT4 signalling." Biochemical Journal 410, no. 2 (March 2008): 255-260.  Full Text
    • Smithers, NP, Hodgkinson, CP, Cuttle, M, and Sale, GJ. "80K-H acts as a signaling bridge in intact living cells between PKCzeta and the GLUT4 translocation regulator Munc18c." Journal of receptor and signal transduction research 28, no. 6 (January 2008): 581-589.  Full Text
    • Decock, J, Long, J-R, Laxton, RC, Shu, X-O, Hodgkinson, C, Hendrickx, W, Pearce, EG, Gao, Y-T, Pereira, AC, Paridaens, R, Zheng, W, and Ye, S. "Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis." Cancer research 67, no. 21 (November 2007): 10214-10221.  Full Text
    • Kyriakou, T, Pontefract, DE, Viturro, E, Hodgkinson, CP, Laxton, RC, Bogari, N, Cooper, G, Davies, M, Giblett, J, Day, INM, Simpson, IA, Albrecht, C, and Ye, S. "Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients." Human molecular genetics 16, no. 12 (June 2007): 1412-1422.  Full Text
    • Sale, EM, Hodgkinson, CP, Jones, NP, and Sale, GJ. "A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNK1, and ATP citrate lyase." Biochemistry 45, no. 1 (January 2006): 213-223.  Full Text
    • Hodgkinson, CP, Mander, A, and Sale, GJ. "Protein kinase-zeta interacts with munc18c: role in GLUT4 trafficking." Diabetologia 48, no. 8 (August 2005): 1627-1636.  Full Text
    • Hodgkinson, CP, Mander, A, and Sale, GJ. "Identification of 80K-H as a protein involved in GLUT4 vesicle trafficking." The Biochemical journal 388, no. Pt 3 (June 2005): 785-793.  Full Text
    • Mander, A, Hodgkinson, CP, and Sale, GJ. "Knock-down of LAR protein tyrosine phosphatase induces insulin resistance." FEBS letters 579, no. 14 (June 2005): 3024-3028.  Full Text
    • Kyriakou, T, Hodgkinson, C, Pontefract, DE, Iyengar, S, Howell, WM, Wong, Y-K, Eriksson, P, and Ye, S. "Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis." Arteriosclerosis, thrombosis, and vascular biology 25, no. 2 (February 2005): 418-423.  Full Text
    • Hodgkinson, CP, and Ye, S. "Microarray analysis of peroxisome proliferator-activated receptor-gamma induced changes in gene expression in macrophages." Biochemical and biophysical research communications 308, no. 3 (August 2003): 505-510.  Full Text
    • Hodgkinson, CP, Sale, EM, and Sale, GJ. "Characterization of PDK2 activity against protein kinase B gamma." Biochemistry 41, no. 32 (August 2002): 10351-10359.  Full Text
    • Hodgkinson, CP, and Sale, GJ. "Regulation of both PDK1 and the phosphorylation of PKC-zeta and -delta by a C-terminal PRK2 fragment." Biochemistry 41, no. 2 (January 2002): 561-569.  Full Text
    • Hodgkinson, CP, Wright, MC, and Paine, AJ. "Fibronectin-mediated hepatocyte shape change reprograms cytochrome P450 2C11 gene expression via an integrin-signaled induction of ribonuclease activity." Molecular Pharmacology 58, no. 5 (November 2000): 976-981.  Full Text
    • Wang, XJ, Hodgkinson, CP, Wright, MC, and Paine, AJ. "Temperature-sensitive mRNA degradation is an early event in hepatocyte de-differentiation." The Biochemical journal 328 ( Pt 3) (December 1997): 937-944.  Full Text
• Teaching & Mentoring
• 

  Recent Courses

  • PHARM 394: Research Independent Study 2016

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.